Pharmaceuticals & Biotechnology · disclosure as of 2026-09-30
Rubicon Research Ltd.
Held by 86 funds in our universe · avg weight 0.79% · range 0.01% to 6.08%
Fundamentals
Current price
₹1436.6
Market cap
₹25,240 cr
P/E (TTM)
87.8
P/B
19.5
ROE
19.1%
Debt / equity
24.13
Revenue growth
+51.6%
Profit margin
14.9%
Dividend yield
0.10%
Technicals · split/bonus-adjusted
From 52-wk high
-22.8%
52-week high
₹1860.6
52-week low
₹577.2
200-day MA
₹1176.2
vs 200D MA
+22.1%
Worst drop 3y
-22.8%
Worst drop all-time
-22.8%
Market-cap class
Small Cap
Price as of 2026-10-22
Funds by category
All (86)
Other – Index Funds (29)
Equity – Sectoral/ Thematic (13)
Other – Other ETFs (8)
Equity – Flexi Cap Fund (6)
Exchange Traded Funds (ETFs) – Equity ETF (5)
Equity – Small Cap Fund (4)
Equity – Multi Cap Fund (4)
Equity – ELSS (3)
Hybrid – Multi Asset Allocation (2)
Hybrid – Dynamic Asset Allocation or Balanced Advantage (2)
Equity – Mid Cap Fund (2)
Equity – Large & Mid Cap Fund (2)
Equity – Focused Fund (1)
Solution Oriented – Retirement Fund (1)
Other – FoF Domestic (1)
Equity – ELSS (legacy) (1)
Equity – Value Fund (1)
Equity – Dividend Yield Fund (1)
Showing only Solution Oriented – Retirement Fund funds. clear filter
1 Solution Oriented – Retirement Fund fund holding this stock , sorted by the stock's weight in each fund
| Fund | Category | % of fund in this stock | As of |
|---|---|---|---|
|
PGIM India Retirement Fund - Direct Plan - Direct Growth
PGIM India Mutual Fund |
Solution Oriented · Retirement Fund | 1.40% | 2026-09-30 |
Holdings sourced from scheme portfolios as published by their AMCs each month under SEBI rules. "% of fund in this stock" is the position weight inside each fund, NOT the rupee value of any individual investor's exposure.